Sign in Pull a receipt

AGIO

AGIOS PHARMACEUTICALS, INC.

Biotechnology · Biotechnology

$257.56 sample

+1.15 (+0.45%) 1D

Market cap

$497.3B

Price as of

2026-10-25

Latest filing

8-K · 2026-10-20

Alerts

8

Price$257.56 +8.36% 3M daily closessample

260.67235.65

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20SEC8-K filed: material event
Oct 15INSInsider buy: General Counsel
Oct 09INSInsider sell: EVP, Operations
Oct 01SECDEF 14A filed
Sep 28INSInsider buy: General Counsel
Sep 17INSInsider buy: General Counsel
Sep 14INSInsider sell: Chief Executive Officer
Sep 04INSInsider sell: EVP, Operations

Sign up to see the real AGIO record →

Company facts

SEC EDGAR registration

Name: AGIOS PHARMACEUTICALS, INC.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +56sample, -100 to +100
Reporting currency: USD

Who is positioning in AGIO

sample

Insiders: 27 insider transactions over 90 days, net selling, $548.1M
Congress: No member trades over 90 days
Institutions · 13F: 21 funds hold $4.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$11.1B +15.9% y/y

Q4 2024Q3 2026

Inventory$6.6B +13.4% y/y

Q4 2024Q3 2026

Accounts receivable$5.0B +15.7% y/y

Q4 2024Q3 2026

Total debt$13.0B +5.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $381.8B -3.1% 3M
Sample peer B: $365.3B +1.6% 3M
Sample peer C: $404.3B +13.6% 3M
Sample peer D: $332.1B +13.5% 3M
Sample peer E: $264.4B -5.1% 3M